Position
Bleichroeder LP in DiaMedica Therapeutics Inc.
Back to the book · All holders of DMAC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$455K$7.96 → $6.77
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 382.3K | $3.04M | — | — | — | 0.5% |
| Q1 2026 | 382.3K | $2.59M | $6.77 | −$455K | −$0 | 0.4% |